Jeffrey Popma, MD, is currently the Director of Invasive Cardiovascular Services at Caritas Christi Health Care System, and the Director, Cardiac Catheterization Laboratories at St. Elizabeth’s Medical Center and Carney Hospital, Boston, MA.   Dr. Popma is also the Director of the Caritas Center for Advanced Cardiovascular Education and Training as well as the Interventional Cardiology Fellowship Training Program at St. Elizabeth’s Medical Center.   Dr. Popma was formerly an Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts.  He was also Director of Interventional Cardiology, Director of the Interventional Cardiology Fellowship Training Program, and Director of the Angiographic Core Laboratory at Brigham and Women’s Hospital, also in Boston from 1998-2007. 

Dr. Popma received his BA from Stanford University, and received an MD with highest distinction from Indiana University School of Medicine. He completed his internship, residency, chief residency and fellowship at University of Texas Southwestern Medical Center.  He also completed an interventional cardiology fellowship at the University of Michigan.  He has been on the faculty at Harvard for the past 7 years.

Dr. Popma is the Past President of the Society for Cardiac Angiography and Intervention.  Dr. Popma sits on the editorial boards of several publications, and reviews for several cardiology periodicals.

Dr. Popma has focused his recent activities on teaching and education curriculum for Interventional Cardiology Training Programs.  Dr. Popma recently co-authored the Interventional Cardiology Section for the American College of Cardiology Self Assessment Program (ACCSAP6) and was Co-Editor for the American College of Cardiology Interventional Cardiology Self Assssment Program (CATHSAP-II).  He was also author of the chapters on “Cardiac Catheterization and Intravascular Ultrasound” and “Percutaneous Coronary and Valvular Intervention” in Braunwalds Heart Disease (7^th Edition).  Dr. Popma has over 280 peer reviewed manuscripts published.

Dr. Popma also directs the Angiographic Core Laboratory principal investigator for over 50 ongoing multicenter device studies.  Over the past 15 years, these trials have included a broad array of new technology, including bare metal stents, drug eluting stents, distal protection devices, total occlusion devices, and carotid and peripheral revascularization procedures.   These trials have been submitted to the FDA and resulting in the approval of these devices in the United States.